AMED Amedisys Inc

Price (delayed)

$244.8

Market cap

$7.97B

P/E Ratio

39.68

Dividend/share

N/A

EPS

$6.17

Enterprise value

$8.23B

Highlights
The net income has soared by 58% YoY and by 10% QoQ
AMED's EPS has soared by 56% YoY and by 9% from the previous quarter
The quick ratio has decreased by 45% YoY but it has increased by 5% QoQ
The company's debt fell by 29% YoY but it rose by 9% QoQ

Key stats

What are the main financial stats of AMED
Market
Shares outstanding
32.57M
Market cap
$7.97B
Enterprise value
$8.23B
Valuations
Price to earnings (P/E)
39.68
Price to book (P/B)
10.2
Price to sales (P/S)
3.79
EV/EBIT
33.49
EV/EBITDA
25.99
EV/Sales
3.89
Earnings
Revenue
$2.12B
EBIT
$245.76M
EBITDA
$316.71M
Free cash flow
$331.51M
Per share
EPS
$6.17
Free cash flow per share
$10.11
Book value per share
$23.99
Revenue per share
$64.58
TBVPS
$17.4
Balance sheet
Total assets
$1.57B
Total liabilities
$783.64M
Debt
$335.12M
Equity
$788.15M
Working capital
-$75.63M
Liquidity
Debt to equity
0.43
Current ratio
0.83
Quick ratio
0.78
Net debt/EBITDA
0.81
Margins
EBITDA margin
15%
Gross margin
43.5%
Net margin
9.5%
Operating margin
11.5%
Efficiency
Return on assets
12.6%
Return on equity
26.2%
Return on invested capital
60.1%
Return on capital employed
22%
Return on sales
11.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMED stock price

How has the Amedisys stock price performed over time
Intraday
-0.85%
1 week
-5.72%
1 month
-4.74%
1 year
36.64%
YTD
-16.54%
QTD
-7.55%

Financial performance

How have Amedisys's revenue and profit performed over time
Revenue
$2.12B
Gross profit
$920.14M
Operating income
$244.25M
Net income
$201.68M
Gross margin
43.5%
Net margin
9.5%
The net income has soared by 58% YoY and by 10% QoQ
The company's net margin rose by 48% YoY and by 7% QoQ
AMED's operating income is up by 38% year-on-year and by 11% since the previous quarter
The company's operating margin rose by 29% YoY and by 8% QoQ

Growth

What is Amedisys's growth rate over time

Valuation

What is Amedisys stock price valuation
P/E
39.68
P/B
10.2
P/S
3.79
EV/EBIT
33.49
EV/EBITDA
25.99
EV/Sales
3.89
AMED's EPS has soared by 56% YoY and by 9% from the previous quarter
The P/E is 16% below the last 4 quarters average of 47.8 and 7% below the 5-year quarterly average of 42.9
The P/B is 54% more than the 5-year quarterly average of 6.7 but 2% less than the last 4 quarters average of 10.5
AMED's equity is up by 16% year-on-year but it is down by 2.6% since the previous quarter
The P/S is 74% more than the 5-year quarterly average of 2.2 but 2.1% less than the last 4 quarters average of 3.9
Amedisys's revenue has increased by 7% YoY and by 2.2% from the previous quarter

Efficiency

How efficient is Amedisys business performance
The ROIC has soared by 69% YoY and by 29% from the previous quarter
The ROE has grown by 28% YoY and by 6% from the previous quarter
The ROA is up by 27% year-on-year and by 8% since the previous quarter
AMED's ROS is up by 26% YoY and by 9% from the previous quarter

Dividends

What is AMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMED.

Financial health

How did Amedisys financials performed over time
AMED's total assets is 101% higher than its total liabilities
The quick ratio has decreased by 45% YoY but it has increased by 5% QoQ
The current ratio has decreased by 44% YoY but it has increased by 5% QoQ
The company's debt is 57% lower than its equity
The debt to equity has contracted by 39% YoY but it has grown by 13% from the previous quarter
The company's debt fell by 29% YoY but it rose by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.